# Tvardi Therapeutics, Inc. (TVRD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Tvardi Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TVRD/mda/fy2025/): filed 2026-03-31; accession 0001104659-26-037729 (https://www.sec.gov/Archives/edgar/data/1346830/000110465926037729/tvrd-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/TVRD/mda/fy2024/): filed 2025-03-11; accession 0001558370-25-002705 (https://www.sec.gov/Archives/edgar/data/1346830/000155837025002705/cara-20241231x10k.htm)
- [FY 2023 MD&A](/company/TVRD/mda/fy2023/): filed 2024-03-06; accession 0001558370-24-002609 (https://www.sec.gov/Archives/edgar/data/1346830/000155837024002609/cara-20231231x10k.htm)
- [FY 2022 MD&A](/company/TVRD/mda/fy2022/): filed 2023-03-06; accession 0001558370-23-002913 (https://www.sec.gov/Archives/edgar/data/1346830/000155837023002913/cara-20221231x10k.htm)
- [FY 2021 MD&A](/company/TVRD/mda/fy2021/): filed 2022-03-01; accession 0001558370-22-002555 (https://www.sec.gov/Archives/edgar/data/1346830/000155837022002555/cara-20211231x10k.htm)

Back to /company/TVRD/